Presepsin can replace procalcitonin in the prediction of sepsis In transplant patients after antithymocyte globulin administration
BACKGROUND-AIM
Sepsis represents a common complication of patients in the emergency department (ED)
and intensive care unit (ICU). The incidence is increasing going along with increasing
admittance of outpatients suspicious for sepsis at the ED. Assessment of disease
severity at the time of initial presentation could be helpful in the patient management as
the mortality of severe sepsis or septic shock is 30 to 60% whereas the mortality of
sepsis without organ failure remains below 10%. The aim of our study was to evaluate
presepsin (PSEP) for assessment of disease severity and outcome prediction in
comparison with the MEDS score.
Sepsis represents a common complication of patients in the emergency department (ED)
and intensive care unit (ICU). The incidence is increasing going along with increasing
admittance of outpatients suspicious for sepsis at the ED. Assessment of disease
severity at the time of initial presentation could be helpful in the patient management as
the mortality of severe sepsis or septic shock is 30 to 60% whereas the mortality of
sepsis without organ failure remains below 10%. The aim of our study was to evaluate
presepsin (PSEP) for assessment of disease severity and outcome prediction in
comparison with the MEDS score.